Overview
Herpes Simplex Virus antibody testing is used to detect an immune response to HSV infection and helps determine past or recent exposure. Herpes Simplex Virus is a double-stranded DNA virus that causes lifelong infection and can remain latent in the body for long periods before reactivation. There are two immunologically distinct types, HSV type 1 and HSV type 2.
HSV-1 is commonly associated with oral infections and lesions above the waist, while HSV-2 is primarily linked to genital infections and lesions below the waist. Antibody testing includes the detection of IgM and IgG antibodies. IgM antibodies appear early after infection and suggest recent infection or reactivation, while IgG antibodies indicate past exposure and usually persist for life. Herpes Simplex Virus antibody testing is widely used for diagnosis, screening, and clinical decision-making in symptomatic and high-risk individuals.
Symptoms
Herpes Simplex Virus infection may be asymptomatic in many individuals, especially during primary infection. When symptomatic, patients may experience tingling, burning, or itching sensations before the appearance of lesions. Painful fluid-filled blisters that rupture and crust over are commonly seen around the mouth, lips, genitals, or anus. Other symptoms include fever, body aches, swollen lymph nodes, and general malaise. Genital involvement may cause pain during urination. In severe cases, especially in newborns or immunocompromised individuals, HSV infection can lead to eczema herpeticum, gingivostomatitis, eye infections, or herpes sepsis.
Causes
HSV antibody positivity is caused by exposure to herpes simplex virus through direct contact with infected skin, mucosal surfaces, or body fluids. HSV-1 is commonly transmitted through oral contact, while HSV-2 is primarily transmitted through sexual contact. After primary infection, the virus establishes latency in sensory nerve ganglia and may reactivate periodically. A positive IgM result suggests recent infection or reactivation, while a positive IgG result indicates past infection. Cross-reactivity and persistence of IgM antibodies can sometimes complicate interpretation.
Risk Factors
Risk factors for Herpes Simplex Virus infection include close personal contact with infected individuals, unprotected sexual activity, multiple sexual partners, and a partner with known HSV infection. Immunocompromised patients, including those with HIV or on immunosuppressive therapy, are at increased risk of severe or recurrent disease.
Pregnant women are considered high risk due to the potential for neonatal herpes. Newborns, especially premature infants, are at higher risk of severe Herpes Simplex Virus complications. High background prevalence in the population also increases exposure risk.
Prevention
Prevention focuses on reducing transmission and early identification of infection. Safe sexual practices, including condom use and awareness of partner Herpes Simplex Virus status, help reduce the spread. Avoiding direct contact with active lesions lowers transmission risk.
Antibody testing helps identify past exposure, assess transmission risk, and guide counseling. Screening in high-risk individuals and pregnant women helps prevent neonatal herpes. Early diagnosis, patient education, and appropriate antiviral management reduce complications and recurrence.
